Weekly Insights & Analysis
Healthcare Private Placement and M&A Transactions Review Week Ending April 27, 2025
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions SHINE Technologies: The company received $122.5 million of development capital from undisclosed investors on April 21, 2025. The company is a developer of medical isotopes designed...
Technology Private Placement and M&A Transactions Review Week Ending April 20, 2025
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Auradine: The company raised $153 million of Series C venture funding in a deal led by StepStone Group on April 16, 2025. Samsung Catalyst Fund, Qualcomm Ventures, MARA holdings,...
Consumer Private Placement and M&A Transactions Review Week Ending April 20, 2025
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions The Ryl Co.: The company raised $15 million of Series B venture funding from Cam Fordham, Alex Dermer and Ben Hiott on April 14, 2025. Austin Neal, Seth England and other undisclosed...
Healthcare Private Placement and M&A Transactions Review Week Ending April 20, 2025
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Glycomine: The company raised $115 million of Series C venture funding in a deal led by Advent Life Sciences and CTI Life Sciences Fund on April 16, 2025. Chiesi Ventures, Novo...
Technology Private Placement and M&A Transactions Review Week Ending April 13, 2025
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Safe Superintelligence: The company raised $2 billion of venture funding in a deal led by Greenoaks Capital Partners on April 13, 2025, putting the company's pre-money valuation at...
A weekly digest of strategy and finance perspectives in charts, together with a review of M&A and private placement transactions by industry sector.